American may receive the Pfizer/BioNTech vaccine on Monday, says US HHS Azar

US Health Secretary Alex Azar has said that Americans might begin receiving the Pfizer/BioNTech COVID-19 vaccine on Monday.
The US Food and Drugs Administration has accelerated work toward finalizing the approval of the vaccine after an advisory panel voted 17 to 4 in favor of granting emergency use. President Donald Trump has urged authorities to move forward with greenlighting the jabs.
The pharmaceutical companies showed a 95% efficacy rate in defending against coronavirus in its Phase 3 test, without showing any severe adverse side effects.
Moderna's incolucaiton also successfully completed its Phase 3 trial and uses the same mRNA technology like Pfizer. The FDA is set to discuss its application on Thursday, December 17.
Author

Yohay Elam
FXStreet
Yohay is in Forex since 2008 when he founded Forex Crunch, a blog crafted in his free time that turned into a fully-fledged currency website later sold to Finixio.
















